Is BXPHF or GBDC a better dividend investment in 2026?

BXPHF currently yields 5000.00% with a 5% 5-year dividend growth rate. GBDC yields 11.86% with 5% growth. The better choice depends on your goal: BXPHF offers higher current income.

What is the dividend yield difference between BXPHF and GBDC?

BXPHF has a forward dividend yield of 5000.00% ($2.00/share annually). GBDC yields 11.86% ($1.50/share annually). The yield gap is 4988.14 percentage points.

Home › Compare › BXPHF vs GBDC

BXPHF vs GBDC: Dividend Comparison 2026

BXPHF yields 5000.00% · GBDC yields 11.86%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BXPHF wins by $62217131802804.50M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BXPHF

● Live price

5000.00%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$62217131802825.35M

Annual income

$59,861,980,287,378,210,000.00

Full BXPHF calculator →

GBDC

● Live price

11.86%

Share price

$12.65

Annual div

$1.50

5Y div CAGR

51.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.85M

Annual income

$16,450,733.83

Full GBDC calculator →

Portfolio growth — BXPHF vs GBDC

📍 BXPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BXPHF	GBDC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BXPHF + GBDC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BXPHF pays

GBDC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BXPHF

Annual income on $10K today (after 15% tax)

$425,000.00/yr

After 10yr DRIP, annual income (after tax)

$50,882,683,244,271,480,000.00/yr

GBDC

Annual income on $10K today (after 15% tax)

$1,007.91/yr

After 10yr DRIP, annual income (after tax)

$13,983,123.76/yr

At 15% tax rate, BXPHF beats the other by $50,882,683,244,257,490,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BXPHF + GBDC for your $10,000?

BXPHF: 50%GBDC: 50%

100% GBDC50/50100% BXPHF

Portfolio after 10yr

$31108565901423.10M

Annual income

$29,930,990,143,697,330,000.00/yr

Blended yield

96.21%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

BXPHF

No analyst data

Price Target

$0.27

+575.0% upside vs current

Range: $0.27 — $0.27

Altman Z

-4.7

Piotroski

3/9

GBDC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$14.00

+10.7% upside vs current

Range: $13.00 — $15.00

Altman Z

0.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BXPHF buys

GBDC buys

No recent congressional trades found for BXPHF or GBDC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBXPHFGBDC

Forward yield	5000.00% ✓	11.86%
Annual dividend / share	$2.00 ✓	$1.50
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	51.1% ✓
Portfolio after 10y	$62217131802825.35M ✓	$20.85M
Annual income after 10y	$59,861,980,287,378,210,000.00 ✓	$16,450,733.83
Total dividends collected	$62057786341622.61M ✓	$20.43M
Payment frequency	quarterly	quarterly
Sector	Stock	BDC
Analyst price target	$0.27	$14.00 ✓

Year-by-year: BXPHF vs GBDC ($10,000, DRIP)

Year	BXPHF Portfolio	BXPHF Income/yr	GBDC Portfolio	GBDC Income/yr	Gap
1← crossover	$510,700	$500,000.00	$12,492	$1,791.70	+$498.2K → BXPHF
2	$24,410,935	$23,864,485.98	$16,527	$3,160.58	+$24.39M → BXPHF
3	$1,092,192,501	$1,066,072,800.30	$23,588	$5,904.90	+$1092.17M → BXPHF
4	$45,746,366,951	$44,577,720,975.17	$37,141	$11,901.65	+$45746.33M → BXPHF
5	$1,793,932,828,410	$1,744,984,215,772.56	$66,205	$26,463.38	+$1793932.76M → BXPHF
6	$65,871,973,805,320	$63,952,465,678,921.49	$137,452	$66,612.65	+$65871973.67M → BXPHF
7	$2,265,146,887,602,700	$2,194,663,875,631,007.20	$342,372	$195,298.53	+$2265146887.26M → BXPHF
8	$72,954,689,148,998,180	$70,530,981,979,263,280.00	$1,053,292	$686,954.33	+$72954689147.94M → BXPHF
9	$2,201,076,182,660,884,700	$2,123,014,665,271,456,500.00	$4,111,439	$2,984,416.95	+$2201076182656.77M → BXPHF
10	$62,217,131,802,825,350,000	$59,861,980,287,378,210,000.00	$20,849,974	$16,450,733.83	+$62217131802804.50M → BXPHF

BXPHF vs GBDC: Complete Analysis 2026

BXPHF — Stock

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.

Full BXPHF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →

📬

Get this BXPHF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BXPHF vs SCHD BXPHF vs JEPI BXPHF vs O BXPHF vs KO BXPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.